1-4 of 4
Mabel Arevalo
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Iadademstat and Gilteritinib for the Treatment of FLT3-Mutated Relapsed/Refractory Acute Myeloid Leukemia: The Frida Study

Amir T. Fathi, Theodore P Braun, Alexander Joseph Ambinder, Gautam Borthakur, Robert L. Redner, Mabel Arevalo, Sonia Gutierrez, Ana Limon, Douglas V. Faller
Journal: Blood
Blood (2023) 142 (Supplement 1): 5974.
https://doi.org/10.1182/blood-2023-189291
Published: 2023
Journal Articles

Iadademstat Combination with Azacitidine Is a Safe and Effective Treatment in First Line Acute Myeloid Leukemia. Final Results of the Alice Trial

Olga Salamero, Tim C.P Somervaille, Antonieta Molero, Evelyn Acuña-Cruz, Jose A. Perez-Simon, Rosa Coll, Montserrat Arnan, Brayan Merchan, Ana Perez, Isabel Cano, Rebeca Rodríguez-Veiga, Mabel Arevalo, Sonia Gutierrez, Carlos Buesa, Douglas V Faller, Francesc Bosch, Pau Montesinos
Journal: Blood
Blood (2022) 140 (Supplement 1): 1711–1713.
https://doi.org/10.1182/blood-2022-168945
Published: 2022
Journal Articles

The Frida Study: An Option for Mutated FLT3 Relapsed/Refractory Acute Myeloid Leukemia Patients with a Novel Iadademstat and Gilteritinib Combination Therapy

Amir T. Fathi, Mabel Arevalo, Sonia Gutierrez, Antonieta Molero, Natalia Sacilotto, Ana Limon, Douglas V Faller
Journal: Blood
Blood (2022) 140 (Supplement 1): 11755–11756.
https://doi.org/10.1182/blood-2022-160427
Published: 2022
Journal Articles

Iadademstat Shows Efficacy in Elderly AML Patients in Combination with Azacitidine. Alice Trial

Carlos Buesa, PhD, Tim CP Somervaille, MD PhD, Mabel Arevalo, PhD, Jordi Xaus, PhD, Sonia Gutierrez, Roger Bullock, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3839.
https://doi.org/10.1182/blood-2019-125121
Published: 2019